• Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch

Scientific Inquirer

  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

COVID

  • Portraits of the Pandemic: Alberto Giuliani and Italian healthcare workers.
    October 16, 2020

    Portraits of the Pandemic: Alberto Giuliani and Italian healthcare workers.

    scientificinquirer
  • The Daily Dose: Scientists come out against COVID-19 herd immunity strategy; Microsoft the crime fighter.
    October 15, 2020

    The Daily Dose: Scientists come out against COVID-19 herd immunity strategy; Microsoft the crime fighter.

    scientificinquirer
  • The Daily Dose: Experts weigh the dangers of COVID-19 infection vs missing routine vaccinations.
    October 14, 2020

    The Daily Dose: Experts weigh the dangers of COVID-19 infection vs missing routine vaccinations.

    scientificinquirer
  • Certain medical procedures pose COVID-19 dangers to healthcare workers
    October 13, 2020

    Certain medical procedures pose COVID-19 dangers to healthcare workers

    scientificinquirer
  • The Daily Dose: Japan forges forward in CO2 fight; The adaptive approach to controlling city traffic.
    October 13, 2020

    The Daily Dose: Japan forges forward in CO2 fight; The adaptive approach to controlling city traffic.

    scientificinquirer
  • Study examines how long COVID-19 immunity lasts.
    October 11, 2020

    Study examines how long COVID-19 immunity lasts.

    scientificinquirer
  • COVID-19 is hitting the homeless hard.
    October 11, 2020

    COVID-19 is hitting the homeless hard.

    scientificinquirer
  • Data suggests COVID-19 may affect ethnic groups differently.
    October 10, 2020

    Data suggests COVID-19 may affect ethnic groups differently.

    scientificinquirer
  • Regeneron antibody cocktail impresses in two studies.
    October 10, 2020

    Regeneron antibody cocktail impresses in two studies.

    scientificinquirer
  • SARS-CoV antibodies are effective against SARS-CoV-2.
    October 9, 2020

    SARS-CoV antibodies are effective against SARS-CoV-2.

    scientificinquirer
Previous Page
1 … 87 88 89 90 91 … 113
Next Page

Categories

Asia.

North America.

Europe.

Africa.

South America.

Australia.

Science For All, Not Just The Few.

Subscribe to our newsletters. We’ll keep you in the loop.

  • Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch
  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

Designed with WordPress

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

Loading Comments...